Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BeOne Medicines Ltd. Director's Dealing 2025

Dec 12, 2025

30073_dirs_2025-12-12_674c7190-e7fb-4056-9a0b-4f12978f5f68.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BeOne Medicines Ltd. (ONC)
CIK: 0001651308
Period of Report: 2025-12-10

Reporting Person: Lee Chan Henry (SVP, General Counsel)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-12-10 American Depositary Shares M 101 $194.47 Acquired 101 Direct
2025-12-10 American Depositary Shares M 133 $213.32 Acquired 234 Direct
2025-12-10 American Depositary Shares M 98 $159.03 Acquired 332 Direct
2025-12-10 American Depositary Shares S 332 $318.28 Disposed 0 Direct
2025-12-11 American Depositary Shares M 101 $194.47 Acquired 101 Direct
2025-12-11 American Depositary Shares M 133 $213.32 Acquired 234 Direct
2025-12-11 American Depositary Shares M 98 $159.03 Acquired 332 Direct
2025-12-11 American Depositary Shares S 332 $325 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-12-10 Share Option (Right to Buy) $14.96 M 1313 Disposed 2032-08-04 Ordinary Shares (1313) Direct
2025-12-10 Share Option (Right to Buy) $16.41 M 1729 Disposed 2033-06-14 Ordinary Shares (1729) Direct
2025-12-10 Share Option (Right to Buy) $12.23 M 1274 Disposed 2034-06-04 Ordinary Shares (1274) Direct
2025-12-11 Share Option (Right to Buy) $14.96 M 1313 Disposed 2032-08-04 Ordinary Shares (1313) Direct
2025-12-11 Share Option (Right to Buy) $16.41 M 1729 Disposed 2033-06-14 Ordinary Shares (1729) Direct
2025-12-11 Share Option (Right to Buy) $12.23 M 1274 Disposed 2034-06-04 Ordinary Shares (1274) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 223106 Direct

Footnotes

F1: Each American Depositary Share represents 13 Ordinary Shares.

F2: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2025.

F3: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares.

F4: These securities vest over a four-year period as follows: 25% on July 29, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F5: These securities vest over a four-year period as follows: 25% on the first anniversary of June 15, 2023 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.

F6: These securities vest over a four-year period as follows: 25% on the first anniversary of June 5, 2024 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.